Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002052113-25-001469·ARROWHEAD PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
ARROWHEAD PHARMACEUTICALS INC COM
Common Stock · CUSIP: 04280A100
Event date: 2025-03-31
- Filing-level shares
- 19,012,855
- Percent of class
- 13.8%
- BlackRock, Inc.
Shares: 19,012,855 · Class: 13.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-001469
- Form type
- SCHEDULE 13G/A
- Filer
- ARROWHEAD PHARMACEUTICALS, INC.
- CIK
- CIK 879407
- Filed
- Apr 23, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership